Cancer · 1984 · 48 citations · 17 references
MedicinePathologyPharmacotherapyChemotherapyPulmonologyRespiratory PharmacotherapyPulmonary PathologyPulmonary ToxicityRespiratory DiseaseRespiratory MedicineRespiratory PathologyChronic Leukemia ChemotherapyChronic Myeloid Leukemia TherapyEtiologic HypothesisFunctional DeteriorationLung Biopsy DiagnosisLung DiseasesLung Mass BiopsyPulmonary Pathogenesis
A 34-year-old woman with typical chronic myelogenous leukemia was treated with daily busulfan (total dose, 1600 mg approximately) from July 1978 to June 1981. In February 1981, she noticed a progressive deterioration of her clinical status, characterized by increasing dyspnea and productive cough. In July 1981, an open lung biopsy revealed pulmonary alveolar proteinosis. The patient died of progressive respiratory failure in August 1981. The association between chronic myelogenous leukemia and pulmonary alveolar proteinosis is briefly reviewed. The report discusses the possible etiologic role of busulfan therapy in the development of pulmonary alveolar proteinosis.
17
Pulmonary Diseases and Disorders
William R. Barclay · JAMA · 1981 · 296 citations
MYLERAN IN CHRONIC MYELOID LEUKÆMIA RESULTS OF TREATMENT
D. A. G. Galton · The Lancet · 1953 · 236 citations
Defective Lung Macrophages in Pulmonary Alveolar Proteinosis
David W. Golde · Annals of Internal Medicine · 1976 · 182 citations
Cytotoxic drug-induced lung disease
H. Dirk Sostman, Richard A. Matthay, Charles E. Putman · The American Journal of Medicine · 1977 · 155 citations
Pharmacy, Pharmacology, Toxicology +10